Hans Walz research grant (study of the history of homeopathy at the Institute for the History of Medi ...
Media
Help Protect Homeopathy in the USA!
At the Faculty of Homeopathy's Congress, Ron Whitmont--the immediate past president of the American Institute of Homeopathy (AIH)--delivered a ...
#ReleaseTheFirstReport – Pressure builds on NHMRC
Join the growing movement calling for the release of the BURIED NHMRC Report on Homeopathy. People from 99 countries are demanding that this ...
A taster of the Congress this year – Homeopathy: Connecting our Global Community – 11-14 October 2018 – Liverpool
A video slide show as a taster of this year's Congress in Liverpool from Thursday, 11th October to Sunday, 14th October 2018 at the Crowne Plaza ...
In Memory of Dr Peter Fisher – Obituaries in the press
Read the ob ...
A homeopathic physician reflects – Dr Nick Avery
Dr Nick Avery now retired talks to Simile about the major influences on this career and how he sees the future for homeopathy in medical practice ...
The War on Natural Medicine – The FDA is threatening homeopathy’s future
The FDA has proposed a new policy for regulating homeopathy—a policy which is a direct threat to many, many homeopathic medicines. To fully protect consumer access to these treatments, our US colleagues need Congress to pass a law.
Congress and the FDA have always exempted homeopathy from the same drug requirements as pharmaceutical drugs. Now the FDA, with pressure from big pharmaceutical companies who compete with homeopathic medicine, wants to create an unnecessary policy. The FDA’s new policy states that no homeopathic medicines have been “generally recognized as safe and effective” (GRAS/E) by the FDA or gone through traditional FDA drug approval; therefore technically speaking all homeopathic medicines currently on the market are being sold illegally. However, the FDA said it would prioritize enforcement on products with safety concerns.
Homeopathy has grown into a $3 billion market with increasing demand from consumers looking for alternatives to prescription medicine.
In response to the FDA’s new proposal, homeopathy advocates are arguing for a return to the Compliance Policy Guide (CPG) used since 1988.